Assessment of liver fibrosis progression in patients with chronic hepatitis C and normal alanine aminotransferase values: The role of AST to the platelet ratio index

被引:27
作者
Carlo, F
Smirne, C
Toniutto, P [1 ]
Colletta, C
Rapetti, R
Minisini, R
Falleti, E
Pirisi, M
机构
[1] Univ Udine, DPMSC Med Liver Transplantat Unit, I-33100 Udine, Italy
[2] Madonna del Popolo Hosp, COQ, Omegna, Italy
[3] Univ Eastern Piedmont A Avogadro, Dept Clin & Expt Med, Novara, Italy
[4] Univ Eastern Piedmont A Avogadro, IRCAD, Novara, Italy
关键词
hepatitis C; liver fibrosis; liver biopsy; serum markers; alcohol; platelet count; alanine aminotransferase;
D O I
10.1016/j.clinbiochem.2006.01.011
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Objectives: To verify the value of indirect scrum markers in the non-invasive assessment of liver fibrosis in patients with persistently normal or near normal alanine aminotransferases levels (NALT). Design and methods: Forty HCV RNA positive, untreated patients with NALT (30 non-drinkers) underwent two liver biopsies, with a median interval of 78.5 months. The AST/ALT ratio, age-platelet index, AST to platelet ratio index (APRI), Foms fibrosis index and Bonacini's discriminant score were simultaneously determined. Results: In 19 patients, worsening of fibrosis was observed at the second biopsy in comparison to the index biopsy. Among non-drinkers, an APRI > 0.4 had a 100% sensitivity in identifying subjects with significant liver fibrosis (Ishak staging score > 2) and an APR <= 0.4 had a 100% negative predictive value in excluding significant liver fibrosis. Conclusions: APRI performs better, in comparison to all other markers, in correctly classifying patients with NALT with no progression to significant liver fibrosis. (c) 2006 The Canadian Society of Clinical Chemists. All rights reserved.
引用
收藏
页码:339 / 343
页数:5
相关论文
共 28 条
[1]   The natural history of hepatitis C [J].
Afdhal, NH .
SEMINARS IN LIVER DISEASE, 2004, 24 :3-8
[2]   Evaluation of liver fibrosis: A concise review [J].
Afdhal, NH ;
Nunes, D .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (06) :1160-1174
[3]   Prevalence of liver disease in a population of asymptomatic persons with hepatitis C virus infection [J].
Alberti, A ;
Noventa, F ;
Benvegnù, L ;
Boccato, S ;
Gatta, A .
ANNALS OF INTERNAL MEDICINE, 2002, 137 (12) :961-964
[5]   Associations between alcohol consumption and insulin sensitivity and cardiovascular disease risk factors - The insulin resistance and atherosclerosis study [J].
Bell, RA ;
Mayer-Davis, EJ ;
Martin, MA ;
D'Agostino, RB ;
Haffner, SM .
DIABETES CARE, 2000, 23 (11) :1630-1636
[6]  
Bonacini M, 1997, AM J GASTROENTEROL, V92, P1302
[7]   Value of two noninvasive methods to detect progression of fibrosis among HCV carriers with normal aminotransferases [J].
Colletta, C ;
Smirne, C ;
Fabris, C ;
Toniutto, P ;
Rapetti, R ;
Minisini, R ;
Pirisi, M .
HEPATOLOGY, 2005, 42 (04) :838-845
[8]   The role of liver biopsy in chronic hepatitis C [J].
Dienstag, JL .
HEPATOLOGY, 2002, 36 (05) :S152-S160
[9]   A comparison of four serum markers of fibrosis in the diagnosis of cirrhosis [J].
Fabris, C ;
Falleti, E ;
Federico, E ;
Toniutto, P ;
Pirisi, M .
ANNALS OF CLINICAL BIOCHEMISTRY, 1997, 34 :151-155
[10]   Factors influencing the rate of fibrosis progression in chronic hepatitis C [J].
Fernández-Rodriguez, CM ;
Gutiérrez, ML ;
Serrano, PL ;
Lledó, JL ;
Santander, C ;
Fernández, TP ;
Tomás, E ;
Cacho, G ;
Nevado, M ;
Casas, ML .
DIGESTIVE DISEASES AND SCIENCES, 2004, 49 (11-12) :1971-1976